Relx plc ADR Stock – Fundamental Analysis

Price
36.93
10/14/2026
Oct 1996
Oct 2026

Fundamental Data & Ratios (Balance sheet update: 10/2/2026)

Balance Sheet Total Assets 14,731,100,000.00 ROE 16.03 %
Balance Sheet Total Equity 2,361,840,000.00 ROA 13.71 %
Cashflow Capital Expenditures -20,539,800.00 P/FCF 17.92
Cashflow Free Cash Flow 2,792,430,080.00 – –
Cashflow Operating Cash Flow 3,819,523,475.39 P/CF 17.82
Income Earnings per Share (diluted) 1.12 Div. Yield 1.84 %
Income Net Income 2,065,000,000.00 P/E 33.57
Income Shares Outstanding 1,819,061,446.00 P/B 28.83
Income Total Revenue 9,379,840,000.00 P/S 7.26

Ratios calculated on: 10/14/2026

Company Description

RELX NV, through its interest in RELX Group plc, provides information and analytics for professional and business customers across industries worldwide. It operates through four segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment offers information and analytics to institutions and professionals. The Risk & Business Analytics segment provides solutions and decision tools that combine public and industry specific content with technology and analytics to evaluate and predict risk, as well as enhance operational efficiency. The Legal segment offers legal, regulatory, and business information and analytics. The Exhibitions segment is involved in the events business. The company was formerly known as Reed Elsevier NV and changed its name to RELX NV in June 2015. RELX NV was incorporated in 1880 and is headquartered in Amsterdam, the Netherlands.

Advanced Analysis Features

Additional comparison and history views are available after login.

Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.relxgroup.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown. Learn more